Committee opinion no. 494: Sulfonamides, nitrofurantoin, and risk of birth defects

Obstetrics and Gynecology

Volumn 117, Issue 6, 2011, Pages 1484-1485

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; GENTAMICIN; METRONIDAZOLE; NITROFURANTOIN; OXACILLIN; PENICILLIN DERIVATIVE; PIVAMPICILLIN; QUINOLONE DERIVATIVE; SULFONAMIDE; URINARY TRACT ANTIINFECTIVE AGENT;

BIRTH DEFECT; DISEASE ASSOCIATION; HUMAN; INFECTION; MATERNAL DISEASE; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; URINARY TRACT INFECTION; ARTICLE; CONGENITAL MALFORMATION; FEMALE; PREGNANCY;

ABNORMALITIES, DRUG-INDUCED; ANTI-INFECTIVE AGENTS, URINARY; FEMALE; HUMANS; NITROFURANTOIN; PREGNANCY; SULFONAMIDES;

EID: 79958131557     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182238c57     Document Type: Review

References (19)

1. Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med 2009;163:978-85.
2. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000;343:1608-14.
3. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. Reprod Toxicol 2001;15:637-46. (Pubitemid 34000933)
4. Czeizel AE, Puho E, Sorensen HT, Olsen J. Possible association between different congenital abnormalities and use of different sulfonamides during pregnancy. Congenit Anom (Kyoto) 2004;44:79-86.
5. Norgard B, Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. Population-based case control study of the safety of sulfasalazine use during pregnancy. Aliment Pharmacol Ther 2001;15:483-6. (Pubitemid 32242773)
6. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based casecontrol teratologic study. Eur J Obstet Gynecol Reprod Biol 2001;97:188-92. (Pubitemid 32645654)
7. Czeizel A. A case-control analysis of the teratogenic effects of co-trimoxazole. Reprod Toxicol 1990;4:305-13.
8. Forna F, McConnell M, Kitabire FN, Homsy J, Brooks JT, Mermin J, et al. Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings. AIDS Rev 2006;8:24-36.
9. Dencker BB, Larsen H, Jensen ES, Schonheyder HC, Nielsen GL, Sorensen HT. Birth outcome of 1886 pregnancies after exposure to phenoxymethylpenicillin in utero. Clin Microbiol Infect 2002;8:196-201. (Pubitemid 34993786)
10. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. A population-based case-control teratologic study of ampicillin treatment during pregnancy. Am J Obstet Gynecol 2001;185:140-7. (Pubitemid 32681808)
11. Larsen H, Nielsen GL, Sorensen HT, Moller M, Olsen J, Schonheyder HC. A follow-up study of birth outcome in users of pivampicillin during pregnancy. Acta Obstet Gynecol Scand 2000;79:379-83. (Pubitemid 30261145)
12. Berkovitch M, Merlob P. Use of cephalosporins during pregnancy and in the presence of congenital abnormalities [letter]. Am J Obstet Gynecol 2002;187:817;author reply 817.
13. Czeizel AE, Sorensen HT, Rockenbauer M, Olsen J. A population-based case-control teratologic study of nalidixic acid. Int J Gynaecol Obstet 2001;73:221-8. (Pubitemid 32455507)
14. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. A teratological study of lincosamides. Scand J Infect Dis 2000; 32:579-80.
15. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. Teratogenic evaluation of oxacillin. Scand J Infect Dis 1999; 31:311-2. (Pubitemid 29389242)
16. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. A population-based case-control teratologic study of oral erythromycin treatment during pregnancy. Reprod Toxicol 1999;13:531-6. (Pubitemid 30017329)
17. Sorensen HT, Larsen H, Jensen ES, Thulstrup AM, Schonheyder HC, Nielsen GL, et al. Safety of metronidazole during pregnancy: a cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women. J Antimicrob Chemother 1999;44:854-6.
18. Schaefer C, Amoura-Elefant E, Vial T, Ornoy A, Garbis H, Robert E, et al. Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS). Eur J Obstet Gynecol Reprod Biol 1996;69:83-9. (Pubitemid 26338311)
19. Larsen H, Nielsen GL, Schonheyder HC, Olesen C, Sorensen HT. Birth outcome following maternal use of fluoroquinolones. Int J Antimicrob Agents 2001;18:259-62. (Pubitemid 32979199)